Feature Vaccine hesitancy: an interview with Stanley Plotkin, rubella vaccine developer BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l6926 (Published 23 December 2019) Cite this as: BMJ 2019;367:l6926 Article Related content Metrics Responses Peer review Related articles No related articles found. See more Polio: What do we know about the polioviruses detected in the UK? BMJ June 27, 2022, 377 o1578; DOI: https://doi.org/10.1136/bmj.o1578 Poliovirus is detected in sewage from north and east London BMJ June 23, 2022, 377 o1546; DOI: https://doi.org/10.1136/bmj.o1546 Covid-19: Omicron infection is poor booster to immunity, study finds BMJ June 15, 2022, 377 o1474; DOI: https://doi.org/10.1136/bmj.o1474 How are vaccines being adapted to meet the changing face of SARS-CoV-2? BMJ June 01, 2022, 377 o1257; DOI: https://doi.org/10.1136/bmj.o1257 Monkeypox: What do we know about the outbreaks in Europe and North America? BMJ May 20, 2022, 377 o1274; DOI: https://doi.org/10.1136/bmj.o1274
